Motley Fool Staff

Motley Fool co-founder David Gardner once again delivers some Foolish wisdom based on his favorite quotes -- and this one is express shipped to us from the CEO of Amazon.com.

Motley Fool co-founder David Gardner once again squeezes some Foolish wisdom out of his favorite quotes -- this one from actor Max Baer Jr.

Motley Fool co-founder David Gardner once again riffs on his favorite quotes, and while he has often been known to quote himself, this time it's his partner in crime who comes through with the bon mot.

Motley Fool co-founder David Gardner is once again riffing on his favorite quotes, and he begins with the one from Shakespeare that gave the company its name.

WFC earnings call for the period ending September 30, 2017

BAC earnings call for the period ending September 30, 2017

Motley Fool co-founder David Gardner stands again on the shoulders of giants and applies their diverse wisdom to the world of personal finance and investing.

Listener Mike is amazed that it's OK for a Wall Street big gun to trash a stock he’s shorting, when his comments are bound to make it fall, thus profiting him.

After this month, the handbag maker will be known as Tapestry.

Investors never like it when a company they own dilutes the value of its outstanding shares, but everyone likes the reverse.

CEO Ed Bastian said the airline performed well despite the hurricanes.

J&J is the lead-off hitter, and its Remicade results will tell us a lot. So will the biosimilar numbers from Pfizer.

The pharmaceutical major announced it's thinking about finding a buyer for its consumer healthcare unit.

C earnings call for the period ending September 30, 2017

Organic growth is the preferred way for most companies to use their profits.

Even though companies generally pay a premium to acquire another business, it can turn out to be a bargain.

There are some good reasons to pay dividends, but it’s not the right move for all companies.

Buying back shares is a good idea in many cases, but there are some exceptions.

According to a well-researched Ad Age article, the answer may be "no."

"Blade Runner 2049" was No. 1 in theaters but came up $20 million short of expectations.